http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102302721-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02898911a9c79256ee95420e73ffecfd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-904 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9366acf747d8a14646ba6d54678afe3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c30e77eb2d9a4e9878a961db0492a58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ffeea9da843343dde88ca6d56a9f88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_538f896811d064248a08c36d7bff39bf |
| publicationDate | 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102302721-B |
| titleOfInvention | Pharmaceutical composition for treating bronchitis as well as preparation method and use thereof |
| abstract | The invention discloses a pharmaceutical composition for treating bronchitis. The pharmaceutical composition is a preparation prepared from the following bulk drugs in parts by weight: 12-18 parts of bulbus fritillariae cirrhosae, 9.6-14.4 parts of tatarian aster root, 4-6 parts of liquorice, 7.2-10.8 parts of dried tangerine peel, 16-24 parts of radix stemonae, 7.2-10.8 parts of willowleaf swallowwort rhizome, 7.2-10.8 parts of platycodon root, 7.2-10.8 parts of herba schizonepeta, 9.6-14.4 parts of bitter apricot seed and 9.6-14.4 parts of radix scutellariae. The pharmaceutical composition has the efficacies of dispelling wind to ventilate the lung and eliminating phlegm for relieving cough, and is suitable for exogenous cough patients with symptoms such as cough and itchy throat, ungratifying expectoration of phlegm or slight fever with aversion to wind; and the pharmaceutical composition has a good effect on relieving cough, eliminating phlegm, relieving asthma, resisting bacteria and diminishing inflammation, thus achieving a better treatment effect on acute bronchitis. The pharmaceutical composition can exert an obvious treatment effect based on medium dosage, and the effect is equivalent to and even superior to that based on high dosage. |
| priorityDate | 2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.